The past six decades have seen remarkable improvements in health outcomes for people
with cystic fibrosis, which was once a fatal disease of infants and young children. However, …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the rapidly
unfolding coronavirus disease 2019 (COVID-19) pandemic 1, 2. Clinical manifestations of …

Background Cystic fibrosis transmembrane conductance regulator (CFTR) modulators correct
the basic defect caused by CFTR mutations. Improvements in health outcomes have been …

Background Cystic fibrosis is caused by mutations in the gene encoding the cystic fibrosis
transmembrane conductance regulator (CFTR) protein, and nearly 90% of patients have at …

Upon activation, neutrophils release DNA fibers decorated with antimicrobial proteins,
forming neutrophil extracellular traps (NETs) 1 , 2 , 3 . Although NETs are bactericidal and …

… Correspondence and requests for reprints should be addressed to Marcus A. Mall, MD,
Pediatric Pulmonology and Cystic Fibrosis Center, Department of Pediatrics III, University of …

Adenine base editing (ABE) enables enzymatic conversion from AT into GC base pairs. ABE
holds promise for clinical application, as it does not depend on the introduction of double-…

Mucociliary clearance is an important primary innate defense mechanism that protects the
lungs from deleterious effects of inhaled pollutants, allergens, and pathogens. Mucociliary …

Chronic lung disease remains the major cause of morbidity and mortality of cystic fibrosis (CF)
patients. Cftr mutant mice developed severe intestinal obstruction, but did not exhibit the …

INTRODUCTION The clinical manifestations of COVID-19 vary from asymptomatic infection
to respiratory failure. Severe disease courses are primarily associated with advanced age, …